3x directors increasing holdings concurrently, I would suggest may signal a bottom either in the company or the greater market. As Australia looks to re-open, those elective surgery delays which have hurt the company bottom line in the last FY may fade this financial year.
With the cost cutting the company has been working on, this would be very positive - but I would like to see where organic growth in the business will come from now that we have slimmed down and are pushing through the challenging times COVID has bought us all.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $678.6M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 40.0¢ | $104.8K | 260.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 66038 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 309109 | 7 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| PGC (ASX) Chart |